$7.94
Today
as of Jul 22, 16:47 ET
Last 30 days
Recent Press Releases & News
RBC Capital Trims CorMedix Price Target to $13 From $14, Maintains Outperform Rating
CorMedix Names Elizabeth Hurlburt as Chief Operating, Commercial Officer
CRMD's Growth Story Expands Beyond DefenCath Into New Trends
Overview
52-week range
$6.13
$17
16% of range
Avg surprise (last 3)
+27.6%
Avg reaction (last 2)
+14.7%
100% positive
Latest IV / EM
63%
EM ±14.5% · $8 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Thu May 14, 2026 | Mar/2026 | $0.43 | $0.35 | +22.9% | +43.3% | +5.7% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $1.26 | — | — | — | — | financials |
| Thu Aug 7, 2025 | Jun/2025 | $0.28 | $0.20 | +40.0% | — | — | earnings |
| Tue May 6, 2025 | Mar/2025 | $0.30 | $0.25 | +20.0% | — | +23.6% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.05 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.25 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.25 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.17 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.25 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Thu Aug 6, 2026 | Jun/2026 | OTHER | $0.26 | $0.28 | -7.1% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | $104M | $40M | $39M | — | $11M | $806,119 |
| Cost of revenue | $12M | — | $8M | $2M | $2M | — | $634,650 | $509,839 |
| Gross profit | $105M | — | $93M | $38M | $37M | — | $11M | $296,280 |
| Operating income | $64M | — | $51M | $20M | $20M | — | $-3M | $-15M |
| Net income | $39M | — | $109M | $20M | $21M | — | $-3M | $-14M |
| EPS (diluted) | $0.43 | — | $1.26 | $0.28 | $0.30 | — | $-0.05 | $-0.25 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $178M | $145M | $48M | $159M | $66M | $41M | $35M | $29M |
| Inventory | $31M | $30M | $29M | $10M | $7M | $8M | $7M | $4M |
| Total current assets | $383M | $367M | $260M | $248M | $145M | $115M | $73M | $53M |
| Total assets | $816M | $826M | $751M | $253M | $150M | $119M | $78M | $58M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $379M | $421M | $377M | $32M | $35M | $34M | $19M | $12M |
| Total equity | $437M | $405M | $374M | $221M | $115M | $85M | $59M | $46M |